retatrutide ly3437943 parkinson's disease clinical trial

retatrutide ly3437943 parkinson's disease clinical trial A Study of (LY3437943) in Participants With Obesity and Cardiovascular (TRIUMPH-3) Liraglutide once daily versus placebo

Name: retatrutide ly3437943 parkinson's disease clinical trial A Study of (LY3437943) in Participants With Obesity and Cardiovascular (TRIUMPH-3) Liraglutide once daily versus placebo
Brand: museeartisanaletruralclion.fr
SKU: 58272884659
Price: 20.43 USD
Availability: InStock
Rating: 4.6264 (27 reviews)

SKU: 58272884659

4.6

USD20.43 USD42.43

Pay in 4 interest-free payments of $5.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 24 - Aug 29

Description

In June 2025, Novo Nordisk, Pay a prepayment of $180 million (approximately RMB 1.293 billion) to Zhuhai United Laboratories in China to obtain global rights for its independently developed three target weight loss drug UBT251 outside of Greater China